Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Immunovant Inc
(NQ:
IMVT
)
38.24
+2.23 (+6.19%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 29, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,431,151
Open
36.18
Bid (Size)
36.22 (1)
Ask (Size)
38.14 (10)
Prev. Close
36.01
Today's Range
36.16 - 40.00
52wk Range
12.40 - 44.19
Shares Outstanding
114,998,871
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Roivant Announces Positive IMVT-1402 Initial 600 mg MAD Results that Confirm Best-in-Class Potential
November 28, 2023
From
Roivant Sciences
Via
GlobeNewswire
Where Immunovant Stands With Analysts
November 15, 2023
Via
Benzinga
Performance
YTD
+103.95%
+103.95%
1 Month
+16.16%
+16.16%
3 Month
+71.25%
+71.25%
6 Month
+82.01%
+82.01%
1 Year
+201.10%
+201.10%
More News
Read More
Recap: Immunovant Q2 Earnings
November 09, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2023
October 13, 2023
Via
Benzinga
The Latest Analyst Ratings for Immunovant
October 09, 2023
Via
Benzinga
Immunovant Inc. (NASDAQ: IMVT) Records 52-Week High Tuesday Morning
September 26, 2023
Via
Investor Brand Network
Lamb Weston, SP Plus And Other Big Stocks Moving Higher On Thursday
October 05, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Stock Market Rally Attempt Underway; Micron, Nike, Amazon, Meta In Focus: Weekly Review
September 29, 2023
Via
Investor's Business Daily
What's Going On Pfizer's Subsidiary Biohaven Stock?
September 27, 2023
Via
Benzinga
Why Sharps Technology Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
September 27, 2023
Via
Benzinga
Biohaven, Yet Another Argenx Rival In Autoimmune Drugs, Just Rocketed 29%
September 27, 2023
Via
Investor's Business Daily
Why Immunovant Stock Is Bolting Higher Today
September 27, 2023
Via
The Motley Fool
Immunovant Parlays Its Shot At Rivaling Argenx Into A $300 Million Offering
September 27, 2023
Via
Investor's Business Daily
MillerKnoll, Hayward Holdings, Ginkgo Bioworks And Other Big Stocks Moving Higher On Wednesday
September 27, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Roivant Stock Price Outlook: Strong Pipeline Is A Catalyst
September 27, 2023
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2023
September 27, 2023
Via
Benzinga
Why Shares of Immunovant Are Soaring on Tuesday
September 26, 2023
Via
The Motley Fool
Nasdaq Down 1.5%; Immunovant Shares Spike Higher
September 26, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's Intraday Session
September 26, 2023
Via
Benzinga
Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
September 26, 2023
Via
Benzinga
Crude Oil Moves Higher; Cintas Earnings Top Estimates
September 26, 2023
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Fisker, Intercept Pharmaceuticals, Immunovant And Other Big Stocks Moving Higher On Tuesday
September 26, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Autoimmune Disease-Focused Immunovant Stock Trading Higher Today?
September 26, 2023
Via
Benzinga
These 2 Biotech Stocks Are Bucking a Down Market Tuesday
September 26, 2023
Via
The Motley Fool
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
September 26, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.